Prostatitis IIIB
Conditions
Interventions
Treatment group:YiQiHuoXueTuoDu Formula + Modified Abdominal and Anal Lifting Exercises + Daily Life Health Promotion
Control group:Tamsulosin hydrochloride extended-release capsules + daily life health promotion
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Meanwhile, it meets the requirements of ?B prostatitis diagnostic standard of modern medicine and Chinese medicine; 2. Male patients aged between 18 and 50 years old; 3. not undergoing prostatitis-related treatment within two weeks prior to enrolment; 4. Patients who voluntarily joined the study, had good compliance and signed the informed consent document.
Exclusion criteria
Exclusion criteria: 1. Persons with a history of allergy to the test drug or low blood pressure and intolerance to the drug; 2. those with severe primary cardiovascular lesions, liver lesions, renal lesions, haematological lesions, pulmonary diseases, or serious diseases affecting their survival, such as tumours or AIDS, which are considered by the investigator to be inappropriate for enrolment. Liver function ALT, AST, renal function BUN more than 50% of the upper limit of normal value, renal function Cr more than the upper limit of normal value, will not be enrolled. 3. Those with severe obstructive diseases of the urinary tract that require surgical treatment; 4. Combined with severe mental and spiritual changes that make it difficult to communicate and cooperate; 5. Patients with other organic diseases of the prostate, such as prostate tumour, benign prostatic hyperplasia, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI; | — |
Secondary
| Measure | Time frame |
|---|---|
| GAD-7;PHQ-9;PSEP;Chronic Prostatitis Chinese Medicine Symptoms Scale;EMG; | — |
Countries
China
Contacts
Public ContactGao Zhan
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed